Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review)

Viral Immunology

Volumn 11, Issue 4, 1998, Pages 167-181

  Menéndez Arias, Luis ^a   Mas, Antonio ^a   Domingo, Esteban ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; GAG PROTEIN; NEF PROTEIN; POL PROTEIN; REV PROTEIN; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENETIC CONSERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROTEIN DOMAIN; REVIEW; VIRUS GENE;

EID: 0032443922     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.167     Document Type: Review

References (81)

1. Bennink, J.R., J.W. Yewdell, and W. Gerhard. 1982. A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone. Nature 296:75-76.
2. Boyer, P.L., A.L. Ferris, P. Clark, J. Whitmer, P. Frank, C. Tantillo, E. Arnold, and S.H. Hughes. 1994. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J. Mol. Biol. 243:472-483.
3. Brander, C., W.J. Pichler, and G. Corradin. 1995. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Clin. Exp. Immunol. 101:107-113.
4. + T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL). Clin. Exp. Immunol. 105:18-25.
5. Brander, C., and B.D. Walker. 1997. Systematic identification of optimal HIV-1 CTL epitopes. In Korber B.T.M., C. Brander, B.F. Haynes, J.P. Moore, R. Koup, and B.D. Walker (eds): HIV molecular immunology database 1997. Theoretical Biology and Biophysics, Los Alamos National Laboratory, New Mexico; part IV, pp. 1-11.
6. Brander, C., K.E. Hartman, A.K. Trocha, N.G. Jones, R.P. Johnson, B. Korber, P. Wentworth, S.P. Buchbinder, S. Wolinsky, B.D. Walker, and S.A. Kalams. 1998. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 101:2559-2566.
7. Cao, H., P. Kanki, J.-L. Sankalé, A. Dieng-Sarr, G.P. Mazzara, S.A. Kalams, B. Korber, S. Mboup, and B.D. Walker. 1997. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J. Virol. 71:8615-8623.
8. Connan, F., F. Hlavac, J. Hoebeke, J.G. Guillet, and J. Choppin. 1994. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur. J. Immunol. 24:777-780.
9. Dalod, M., M. Harzic, I. Pellegrin, B. Dumon, B. Hoen, D. Sereni, J.-C. Deschemin, J.-P. Levy, A. Venet, and E. Gomard. 1998. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J. Infect. Dis. 178:61-69.
10. De Groot, A.S., M. Clerici, A. Hosmalin, S.H. Hughes, D. Barnd, C.W. Hendrix, R. Houghten, G.M. Shearer, and J.A. Berzofsky. 1991. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: Correlation with a cytotoxic T cell epitope. J. Infect. Dis. 164:1058-1065.
11. Domingo, E., L. Menéndez-Arias, M.E. Quiñones-Mateu, A. Holguín, M. Gutiérrez-Rivas, M.A. Martínez, J. Quer, I.S. Novella, and J.J. Holland. 1997. Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. In E. Jucker (ed.): Progress in drug research, vol. 48. Birkhäuser Verlag, Basel, Switzerland; pp. 99-128.
12. Durali, D., J. Morvan, F. Letourneur, D. Schmitt, N. Guegan, M. Dalod, S. Saragosti, D. Sicard, J.-P. Levy, and E. Gomard. 1998. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J. Virol. 72:3547-3553.
13. Fernández-Vin̄a, M.A., M. Falco, Y. Sun, and P. Stastny. 1992. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum. Immunol. 33:163-173.
14. Goulder, P., D. Price, M. Nowak, S. Rowland-Jones, R. Phillips, and A. McMichael. 1997. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol. Rev. 159:17-29.
15. Goulder, P.J.R., S.W. Reid, D.A. Price, C.A. O'Callaghan, A.J. McMichael, R.E. Phillips, and E.Y. Jones. 1997. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur. J. Immunol. 27:1515-1521.
16. Goulder, P.J.R., A.K. Sewell, D.G. Lalloo, D.A. Price, J.A. Whelan, J. Evans, G.P. Taylor, G. Luzzi, P. Giangrande, R.E. Phillips, and A.J. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433.
17. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R.P. Johnson, S. Buchbinder, and B.D. Walker. 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476-479.
18. Haynes, B.F., G. Pantaleo, and A.S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324-328.
19. Hosmalin, A., M. Clerici, R. Houghten, C.D. Pendleton, C. Flexner, D.R. Lucey, B. Moss, R.N. Germain, G.M. Shearer, and J.A. Berzofsky. 1990. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 87:2344-2348.
20. Ikeda-Moore, Y., H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: Strong epitopes are derived from V regions of HIV-1. J. Immunol. 159:6242-6252.
21. Jacobo-Molina, A., J. Ding, R.G. Nanni, A.D. Clark, Jr., X. Lu, C. Tantillo, R.L. Williams, G. Kamer, A.L. Ferns, P. Clark, A. Hizi, S.H. Hughes, and E. Arnold. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
22. Jassoy, C., T. Harrer, T. Rosenthal, B.A. Navia, J. Worth, R.P. Johnson, and B.D. Walker. 1993. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-α), and TNF-β when they encounter their target antigens. J. Virol. 67:2844-2852.
23. Johnson, R.P., and B.D. Walker. 1994. Cytotoxic T lymphocytes in human immunodeficiency virus infection: Responses to structural proteins. Curr. Topics Microbiol. Immunol. 189:35-63.
24. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, H.S. Ngo, R.T. D'Aquila, J.T. Kurnick, and B.D. Walker. 1994. Longitudinal analysis of T cell receptors (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179: 1261-1271.
25. Kaslow, R.A., M. Carrington, R. Apple, L. Park, A. Munoz, A.J. Saah, J.J. Goedert, C. Winkler, S.J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D.L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2:405-411.
26. Klein, M.R., S.H. van den Burg, E. Hovenkamp, A.M. Holwerda, J.W. Drijfhout, C.J.M. Melief, and F. Miedema. 1998. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J. Gen Virol. 79:2191-2201.
27. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Köppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R.E. Phillips, and A.J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403-407.
28. Klenerman, P., U.-C. Meier, R.E. Phillips, and A.J. McMichael. 1995. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immunol. 25:1927-1931.
29. Kohlstaedt, L.A., J. Wang, J.M. Friedman, P.A. Rice, and T.A. Steitz. 1992. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
30. Kónya, J., G. Stuber, A. Björndal, E.M. Fenyö, and J. Dillner. 1997. Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 protease. J. Gen. Virol. 78:2217-2224.
31. Korber, B.T.M., C. Brander, B.F. Haynes, J.P. Moore, R. Koup, and B.D. Walker (eds.). 1997. HIV molecular immunology database 1997. Theoretical Biology and Biophysics, Los Alamos National Laboratory, New Mexico; part I, pp. 29-43.
32. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
33. Larder, B.A., S.D. Kemp, and D.J.M. Purifoy. 1989. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc. Natl. Acad. Sci. USA 86:4803-4807.
34. Letvin, N.L. 1998. Progress in the development of an HIV-1 vaccine. Science 280:1875-1880.
35. Lieberman, J., J.A. Fabry, M.-C. Kuo, P. Earl, B. Moss, and P.R. Skolnik. 1992. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gp160 and reverse transcriptase. J. Immunol. 148:2738-2747.
36. + cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92:2308-2312.
37. Martín-Hernández, A.M., M. Gutiérrez-Rivas, E. Domingo, and L. Menéndez-Arias. 1997. Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptase with amino acid substitutions affecting Tyr115. Nucleic Acids Res. 25:1383-1389.
38. McMichael, A. 1998. T cell responses and viral escape. Cell 93:673-676.
39. McMichael, A.J., and R.E. Phillips. 1997. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:271-296.
40. Meier, U.-C., P. Klenerman, P. Griffin, W. James, B. Köppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360-1362.
41. Menéndez-Arias, L. and E. Domingo. 1998. Resistance tables for antiretroviral drugs. AIDS Cyber J. 1:95-127.
42. Moss, P.A.H., S.L. Rowland-Jones, P.M. Frodsham, S. McAdam, P. Giangrande, A. McMichael, and J.I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA 92:5773-5777.
43. Musey, L., Y. Hu, L. Eckert, M. Christensen, T. Karchmer, and M.J. McElrath. 1997. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. Med. 185:293-303.
44. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M.J. McElrath. 1997. Cytotoxic T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
45. Nixon, D.F., A.R.M. Townsend, J.G. Elvin, C.R. Rizza, J. Gallwey, and A.J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484-487.
46. Oldstone, M.B.A. (ed.). 1994. Cytotoxic T-lymphocytes in human viral and malaria infections. Curr. Top. Microbiol. Immunol. 189.
47. Ogg, G.S., X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A. Nowak, S. Monard, J.P. Segal, Y. Cao, S.L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D.D. Ho, D.F. Nixon, and A.J. McMichael. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
48. Pantaleo, G., and A.S. Fauci. 1996. Immunopathogenesis of HIV infection. Annu. Rev. Immunol. 50:825-854.
49. Parker, K.C., M.A. Bednarek, L.K. Hull, U. Utz, B. Cunningham, H.J. Zweerink, W.E. Biddison, and J.E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149:3580-3587.
50. Plata, F., B. Autran, L.P. Martins, S. Wain-Hobson, M. Raphael, C. Mayaud, M. Denis, J.M. Guillon, and P. Debre. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328:348-351.
51. Pogue, R.R., J. Eron, J.A. Frelinger, and M. Matsui. 1995. Ammo-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. USA 92:8166-8170.
52. + T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitope. Clin. Immunol. Immunopathol. 74:100-106.
53. Rausch, J.W., and S.F.J. Le Grice. 1997. Reverse transcriptase-associated ribonuclease H activity as a target for antiviral chemotherapy. Antivir. Chem. Chemother. 8:173-185.
54. Riviere, Y., M.N. Robertson, and F. Buseyne. 1994. Cytotoxic T lymphocytes in human immunodeficiency virus infection: Regulator genes. Curr. Topics Microbiol. Immunol. 189:65-74.
55. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59-64.
56. Rowland-Jones, S., R. Tan, and A. McMichael. 1997. Role of cellular immunity in protection against HIV infection. Adv. Immunol. 65:277-346.
57. Schrier, R.D., J.W. Gnann, Jr., R. Landes, C. Lockshin, D. Richman, A. McCutchan, C. Kennedy, M.B.A. Oldstone, and J.A. Nelson. 1989. T cell recognition of HIV synthetic peptides in a natural infection. J. Immunol. 142:1166-1176.
58. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H.-G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10:1075-1083.
59. Sipsas, N.V., S.A. Kalams, A. Trocha, S. He, W.A. Blattner, B.D. Walker, and R.P. Johnson. 1997. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 99:752-762.
60. Sutton, J., S. Rowland-Jones, W. Rosenberg, D. Nixon, F. Gotch, X.-M. Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith, A. Willis, and A. McMichael. 1993. A sequence pattern for peptides presented to cytotoxic T lympho-cytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447-453.
61. Telesnitsky, A., and S.P. Goff. 1997. Reverse transcriptase and the generation of retroviral DNA. In Coffin J.M., S.H. Hughes, and H.E. Varmus (eds.): Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York; pp. 121-160.
62. Threlkeld, S.C., P.A. Wentworth, S.A. Kalams, B.M. Wilkes, D.J. Ruhl, E. Keogh, J. Sidney, S. Southwood, B.D. Walker, and A. Sette. 1997. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily. Implications for vaccine development. J. Immunol. 159:1648-1657.
63. Tomiyama, H., K. Miwa, H. Shiga, Y.I. Moore, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J. Immunol. 158:5026-5034.
64. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA 88:11276-11280.
65. Tsomides, T.J., A. Aldovini, R.P. Johnson, B.D. Walker, R.A. Young, and H.N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
66. Van Baalen, C.A., O. Pontesilli, R.C. Huisman, A.M. Geretti, M.R. Klein, F. De Wolf, F. Miedema, R.A. Gruters, and A.D.M.E. Osterhaus. 1997. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 78:1913-1918.
67. Van Baalen, C.A., M. Schutten, R.C. Huisman, P.H.M. Boers, R.A. Gruters, and D.M.E. Osterhaus. 1998. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J. Virol. 72:6851-6857.
68. Van der Burg, S.H., M.R. Klein, C.J.H. van de Velde, W.M. Kast, F. Miedema, and C.J.M. Melief. 1995. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121-127.
69. Van der Burg, S.H., M.J.W. Visseren, R.M.P. Brandt, W.M. Kast, and C.J.M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308-3314.
70. Van der Burg, S.H., M.R. Klein, O. Pontesilli, A.M. Holwerda, J.-W. Drijfhout, W.M. Kast, F. Miedema, and C.J.M. Melief. 1997. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS. J. Immunol. 159:3648-3654.
71. Wakefield, J.K., S.A. Jablonski, and C.D. Morrow. 1992. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. J. Virol. 66:6806-6812.
72. Walker, B.D. 1990. HIV-1-specific cytotoxic T lymphocytes. In Aldovini A., and B.D. Walker (eds.): Techniques in HIV research. Stockton Press, New York; pp. 201-209.
73. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Durno, R.S. Blumberg, J.C. Kaplan, M.S. Hirsch, and R.T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348.
74. Walker, B.D., C. Flexner, T.J. Paradis, T.C. Fuller, M.S. Hirsch, R.T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64-66.
75. Walker, B.D., C. Flexner, K. Birch-Limberger, L. Fisher, T.J. Paradis, A. Aldovini, R. Young, B. Moss, and R.T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514-9518.
76. Walter, J.B., C. Brander, M. Mammen, D.N. Garboczi, S.A. Kalams, G.M. Whitesides, B.D. Walker, and H.N. Eisen. 1997. Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes. Int. Immunol. 9:451-459.
77. Wrobel, J.A., S.-F. Chao, M.J. Conrad, J.D. Merker, R. Swanstrom, G.J. Pielak, and C.A. Hutchison III. 1998. A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 95:638-645.
78. Yang, O.O., S.A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B.D. Walker, and R.P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70:5799-5806.
79. + cells: Evidence of HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
80. Zhang, Q.-J., R. Gavioli, G. Klein, and M.G. Masucci. 1993. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA 90:2217-2221.
81. Zinkernagel, R.M., and P.C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701-702.